Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
1(6%)
Results Posted
18%(2 trials)

Phase Distribution

Ph not_applicable
4
25%
Ph phase_3
2
13%
Ph early_phase_1
2
13%
Ph phase_1
1
6%
Ph phase_4
3
19%
Ph phase_2
4
25%

Phase Distribution

3

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
2(12.5%)
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
4(25.0%)
Phase 3Large-scale testing
2(12.5%)
Phase 4Post-market surveillance
3(18.8%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(2)
Completed(11)
Terminated(2)
Other(1)

Detailed Status

Completed11
Withdrawn2
Not yet recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (12.5%)
Phase 11 (6.3%)
Phase 24 (25.0%)
Phase 32 (12.5%)
Phase 43 (18.8%)
N/A4 (25.0%)

Trials by Status

withdrawn213%
not_yet_recruiting16%
unknown16%
completed1169%
recruiting16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT06750653Phase 4

Skin Barrier Function and Inflammation in Aging: The BIA Study

Recruiting
NCT07408960Not Applicable

CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial

Not Yet Recruiting
NCT07169032Early Phase 1

The Effect of Er,Cr:YSGG Laser-assisted Topical Anesthetic on Oral Mucosal Anesthesia

Completed
NCT04329221Phase 2

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Withdrawn
NCT04642287Phase 2

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Withdrawn
NCT05449392Phase 1

Topical Antibacterial Agents for Prevention of COVID-19

Completed
NCT03447925Phase 2

Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients

Completed
NCT03279328Phase 4

Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents

Completed
NCT03946826Not Applicable

A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis

Completed
NCT03095872Phase 3

Comparison of the Effect of Vaseline and Bepanthen® "Wund- Und Heilsalbe" on the Wound Healing Following Laser Therapy

Completed
NCT02801305Phase 2

Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers

Completed
NCT02019355Early Phase 1

Actinic Keratosis Study

Completed
NCT00812604Not Applicable

Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain

Completed
NCT01078428Phase 4

Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars

Completed
NCT01756664Not Applicable

The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing

Unknown
NCT01512017Phase 3

Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16